Expression of c-Met Is Different along the Location and Associated with Lymph Node Metastasis of Head and Neck Carcinoma
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Activation of the c-Met pathway is involved in cancer progression and the prognosis. We aimed to identify any association of c-Met protein expression with a number of clinicopathologic variables including infection of human papillomavirus and Epstein-Barr virus (EBV) in head and neck carcinomas (HNCa). Methods: Eighty-two cases were enrolled in this study. Expression of c-Met and p16 was investigated immunohistochemically. EBV was detected by in situ hybridization andamplification of the c-Met gene by fluorescence in situ hybridization. Results: The c-Met protein was expressed in 41.5% (34/82), and gene amplification was found in 1.4% (1/71). High expression of c-Met was associated with the primary location of the tumor; the hypopharynx showed the highest expression, followed by the oral cavity, larynx, and nasal cavity. Squamous cell carcinoma expressed c-Met more frequently than undifferentiated carcinoma. Also, p16 immunoreactivity or EBV infection was associated with the tumor location and well-differentiated histologic type, but were not linked to c-Met expression. The patients with positive c-Met expression showed frequent lymph node metastasis. Conclusions: Activation of the c-Met pathway might be involved in a subset of HNCa. Cases showing positive c-Met expression should be carefully monitored because of the high probability of lymph node metastasis.
Abstract
Background: Activation of the c-Met pathway is involved in cancer progression and the prognosis. We aimed to identify any association of c-Met protein expression with a number of clinicopathologic variables including infection of human papillomavirus and Epstein-Barr virus (EBV) in head and neck carcinomas (HNCa). Methods: Eighty-two cases were enrolled in this study. Expression of c-Met and p16 was investigated immunohistochemically. EBV was detected by in situ hybridization andamplification of the c-Met gene by fluorescence in situ hybridization. Results: The c-Met protein was expressed in 41.5% (34/82), and gene amplification was found in 1.4% (1/71). High expression of c-Met was associated with the primary location of the tumor; the hypopharynx showed the highest expression, followed by the oral cavity, larynx, and nasal cavity. Squamous cell carcinoma expressed c-Met more frequently than undifferentiated carcinoma. Also, p16 immunoreactivity or EBV infection was associated with the tumor location and well-differentiated histologic type, but were not linked to c-Met expression. The patients with positive c-Met expression showed frequent lymph node metastasis. Conclusions: Activation of the c-Met pathway might be involved in a subset of HNCa. Cases showing positive c-Met expression should be carefully monitored because of the high probability of lymph node metastasis.
참고문헌 (25)
- National Cancer Center. Annual report of cancer statistics in Korea in 2009, "The Korea Central Cancer Registry", Ministry of Health and Welfare, ~ (2011)
- Siegel R, "Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths", CA Cancer J Clin, 61, pp.212~236 (2011)
- Szabó B, "Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas", Oral Oncol, 47, pp.487~496 (2011)
- Lau PC, "Novel therapeutic target for head and neck squamous cell carcinoma: HGF-MET signaling pathway", Anticancer Drugs, 22, pp.665~673 (2011)
- Organ SL, "An overview of the c-MET signaling pathway", Ther Adv Med Oncol, 3(1 Suppl), pp.7~19 (2011)
- Birchmeier C, "Met, metastasis, motility and more", Nat Rev Mol Cell Biol, 4, pp.915~925 (2003)
- Eder JP, "Novel therapeutic inhibitors of the c-Met signaling pathway in cancer", Clin Cancer Res, 15, pp.2207~2214 (2009)
- Olaussen KA, "DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy", N Engl J Med, 355, pp.983~991 (2006)
- Varella-Garcia M, "EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer", J Clin Pathol, 62, pp.970~977 (2009)
- Cappuzzo F, "Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients", J Clin Oncol, 27, pp.1667~1674 (2009)
- 고현정, "High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer", JOURNAL OF THORACIC ONCOLOGY, 5, pp.305~313, LIPPINCOTT WILLIAMS & WILKINS
- Kim CH, "c-Met expression as an indicator of survival outcome in patients with oral tongue carcinoma", Head Neck, 32, pp.1655~1664 (2010)
- Endo K, "Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma", Hum Pathol, 37, pp.1111~1116 (2006)
- Lo Muzio L, "Effect of c-Met expression on survival in head and neck squamous cell carcinoma", Tumour Biol, 27, pp.115~121 (2006)
- Xie LQ, "Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma", Ann Surg Oncol, 17, pp.1927~1936 (2010)
- Qian CN, "Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma", Cancer Res, 62, pp.589~596 (2002)
- Sawatsubashi M, "Expression of c-Met in laryngeal carcinoma", Virchows Arch, 432, pp.331~335 (1998)
- Kim CH, "Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma", ACTA OTO-LARYNGOLOGICA, 126, pp.88~94 (2006)
- Knowles LM, "HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer", Clin Cancer Res, 15, pp.3740~3750 (2009)
- Walker F, "Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus", Clin Cancer Res, 9, pp.273~284 (2003)
- Horikawa T, "Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma", Am J Pathol, 159, pp.27~33 (2001)
- Kijima Y, "Amplification and overexpression of c-met gene in Epstein-Barr virus-associated gastric carcinomas", Oncology, 62, pp.60~65 (2002)
- Schlecht NF, "A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer", Mod Pathol, 24, pp.1295~1305 (2011)
- Singhi AD, "Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience", Cancer, 116, pp.2166~2173 (2010)
- Seiwert TY, "The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma", Cancer Res, 69, pp.3021~3031 (2009)